Advancis Pharmaceutical Corporation to Build Office/Research Facility in Germantown Maryland.Business Editors/Health & Medical Writers BIOWIRE2K GAITHERSBURG, Md.--(BW HealthWire)--July 31, 2002 Specialty Pharmaceutical Company Will Employ 150 at New Building Financed With State, Montgomery County Montgomery County may refer to:
Advancis Pharmaceutical Corporation, a privately-held specialty pharmaceutical company focused on the development and commercialization of novel anti-infective products, today announced that it is building a new company headquarters and research facility in Germantown, Maryland. Advancis expects to employ more than 150 professionals to staff the facility, which represents an investment in property and equipment valued at more than $15 million, made possible in part through commitments by State of Maryland and Montgomery County agencies. The company expects to relocate its current staff of 50 employees to the new facility by June 2003. Located 5 miles north of the company's current headquarters along the I-270 Biotech bi·o·tech n. Informal Biotechnology. biotech Noun short for biotechnology Noun 1. Corridor, the Germantown facility is a key step in Advancis' long-term business strategy to develop and bring to market a wide portfolio of new anti-infective drug therapies. The building will encompass 62,000 square feet of office and research space in the Seneca Meadows Corporate Center, leased from Minkhoff Development Corporation. Advancis will initially outfit the building's research facilities with approximately $6 million in capital equipment. The building will be financed by Allfirst Bank, The Maryland Industrial Financing Authority (MIDFA) and a grant from the Montgomery County Department of Economic Development. Montgomery County has worked to attract and promote promising biotechnology businesses since the 1980s. "Today Advancis establishes a foundation for the future of our company and a long, prosperous relationship with Montgomery County, the state of Maryland and the local communities where our employees will live and work," said Edward M. Rudnic, Ph.D., president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Advancis. "Our new home in Germantown will be a model workplace and a state-of-the-art drug development facility, where we will draw upon the abundance of home-grown talent to develop and market a range of new and effective medicines." "I am pleased that Advancis has chosen to locate in Montgomery County," said County Executive Douglas M. Duncan. "This project is the kind of long term commitment and sensible development that the County has encouraged for many years. We wish them success in Montgomery County." Advancis expects to occupy over 80% percent of the Germantown facility by June 2003, with total occupancy and construction completed by 2004. The architect team for the project is headed by William Gaudreau, Jr., of Gaudreau Inc., a Baltimore-based firm with almost 20 years of experience designing pharmaceutical laboratories, including labs for Celera Genomics and Human Genome Sciences Human Genome Sciences NASDAQ: HGSI is a biopharmaceutical corporation founded in 1992. Its stated purpose is to "discover, develop, manufacture and market innovative drugs that serve patients with unmet medical needs, with a primary focus on protein and antibody drugs. in Montgomery County. The contractor is Barclay White Skanska, Inc. of Rockville, Maryland Rockville is the county seat of Montgomery County, Maryland, United States. According to the 2006 census update, the city had a total population of 59,114, making it the second largest city in Maryland. , headed by David Miller David Miller could refer to any of the following:
Peter Black, Scott Ensor and Hugh Giorgio of Allfirst Bank, Greg Cole and Beth Woodring of MIDFA, and David Edgerly and Henry Bernstein of the Montgomery County Department of Economic Development participated in securing Advancis' financing arrangements. About Advancis Pharmaceutical Corporation: Advancis is a privately held specialty pharmaceutical company focused on the development and commercialization of anti-infective therapeutics therapeutics Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry. . Advancis has developed a once-daily drug delivery technology, Pulsys(TM), which delivers rapid sequential pulsatile pulsatile /pul·sa·tile/ (pul´sah-til) characterized by a rhythmic pulsation. pul·sa·tile adj. Undergoing pulsation. pulsatile characterized by a rhythmic pulsation. dosing of antibiotics Antibiotics Definition Antibiotics may be informally defined as the subgroup of anti-infectives that are derived from bacterial sources and are used to treat bacterial infections. to improve drug efficacy. By examining the resistance patterns of bacteria and applying its improved drug delivery technologies, Advancis has the potential to re-define the paradigm of bacterial infection treatment and significantly improve currently marketed antibacterial antibacterial /an·ti·bac·te·ri·al/ (-bak-ter´e-al) destroying or suppressing growth or reproduction of bacteria; also, an agent that does this. an·ti·bac·te·ri·al adj. products. For more on Advancis, please visit www.advancispharm.com. |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion